MedTrace Logo

PET/MR Imaging in Lung Cancer

NCT03739281 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 35

Last updated 2023-01-17

No results posted yet for this study

Summary

The purpose of this project is to investigate if PET/MR imaging improves the accuracy in visualization and characterization of lung cancer disease, compared to PET/CT.

Conditions

Interventions

DIAGNOSTIC_TEST

PET/MR

The included patients are imaged with PET/MR as part of the research protocol.

DIAGNOSTIC_TEST

PET/CT

The included patients are imaged with PET/CT as part of normal clinical routine.

Sponsors & Collaborators

  • University Hospital of North Norway

    lead OTHER

Principal Investigators

  • Rune Sundset, MD, PhD · University Hospital of North Norway

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-12-12
Primary Completion
2022-12-31
Completion
2022-12-31

Countries

  • Norway

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03739281 on ClinicalTrials.gov